title: Bilateral enucleation avoided by excision with mitomycin C for bilateral infiltrating conjunctival squamous cell carcinoma in a girl with xeroderma pigmentosum.
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco. Electronic address: sophiaelhamichi@gmail.com.
authors.forename: S
authors.initials: S
authors.lastname: El Hamichi
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco.
authors.forename: R
authors.initials: R
authors.lastname: Messaoudi
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco.
authors.forename: M
authors.initials: M
authors.lastname: Belmalih
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco.
authors.forename: S
authors.initials: S
authors.lastname: Iferkhass
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco.
authors.forename: R
authors.initials: R
authors.lastname: Zerrouk
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco.
authors.forename: K
authors.initials: K
authors.lastname: Reda
authors.affiliation: Service d'ophtalmologie, hôpital militaire d'instruction Mohammed V, Madinat Al Irfane, Rabat, Morocco.
authors.forename: A
authors.initials: A
authors.lastname: Oubaaz
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology / Q000601:surgery; D002648:Child; D003131:Combined Modality Therapy; D003230:Conjunctival Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology / Q000601:surgery; D003241:Consanguinity; D000075202:Contraindications; D017679:Cryotherapy; D015353:Eye Enucleation; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D016685:Mitomycin / Q000008:administration & dosage / Q000627:therapeutic use*; D009361:Neoplasm Invasiveness; D009381:Neoplasms, Radiation-Induced / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology / Q000601:surgery; D016609:Neoplasms, Second Primary; D009883:Ophthalmic Solutions; D013508:Ophthalmologic Surgical Procedures; D012074:Remission Induction; D012878:Skin Neoplasms / Q000209:etiology; D013472:Sunlight / Q000009:adverse effects; D014983:Xeroderma Pigmentosum / Q000145:classification / Q000150:complications* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D009883:Ophthalmic Solutions; D016685:Mitomycin